MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jpm15060241

Медицинская библиотека · Journal of personalized medicine · 2025

The Role of Ventricular Assist Devices in Patients with Ischemic vs. Non-Ischemic Cardiomyopathy.

Rumbinaitė Eglė, Karčiauskas Dainius, Ramantauskaitė Grytė, Verikas Dovydas, Žūkaitė Gabrielė, Rancaitė Liucija, Jociutė Barbora, Šakalytė Gintarė, Žaliūnas Remigijus

СтатьяПеревод пока не подготовлен

Аннотация

Background

The HeartMate 3 (HM3) left ventricular assist device (LVAD) has demonstrated improved clinical outcomes in patients with advanced heart failure (HF). However, the influence of underlying HF etiology-ischemic cardiomyopathy (ICM) versus dilated cardiomyopathy (DCM)-on post-implantation outcomes remains insufficiently characterized.

Objectives

This paper aims to evaluate early postoperative outcomes following HM3 LVAD implantation in patients with ICM versus DCM and to identify the preoperative hemodynamic and clinical predictors of early mortality and hemodynamic instability.

Methods

We conducted a retrospective single-center cohort study of 30 patients who underwent HM3 LVAD implantation between 2017 and 2024. Patients were stratified by HF etiology (ICM, n = 17; DCM, n = 13), and preoperative clinical, echocardiographic, and right heart catheterization data were analyzed. The primary endpoint was 30-day postoperative survival. Secondary endpoints included postoperative hemodynamic stability and the need for vasopressor support.

Results

Non-survivors (n = 13) demonstrated elevated central venous pressure (>16.5 mmHg), mean right ventricular pressure (>31.5 mmHg), and pulmonary vascular resistance (>7.5 Wood units), in addition to higher preoperative creatinine levels and longer cardiopulmonary bypass times. Vasopressor requirement postoperatively was associated with elevated pre-implant systolic pulmonary artery pressure.

Conclusions

Preoperative right-sided pressures and renal dysfunction are strong predictors of early mortality following HM3 LVAD implantation. Patients with ICM exhibit greater early left ventricular recovery compared to those with DCM. These findings underscore the importance of comprehensive and personalized preoperative risk stratification-particularly in patients with DCM and pulmonary hypertension-to optimize postoperative outcomes and guide patient selection for durable LVAD support.

Для цитирования: Rumbinaitė Eglė, Karčiauskas Dainius, Ramantauskaitė Grytė, Verikas Dovydas, Žūkaitė Gabrielė, Rancaitė Liucija, Jociutė Barbora, Šakalytė Gintarė, Žaliūnas Remigijus. The Role of Ventricular Assist Devices in Patients with Ischemic vs. Non-Ischemic Cardiomyopathy.. Journal of personalized medicine. 2025. DOI: 10.3390/jpm15060241.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.